Failure of successful renal transplant to produce appropriate levels of 1,25-dihydroxyvitamin D (original) (raw)

• Siddiqi N, McBride M, Hariharan S (2004) Similar risk profiles for post-transplant renal dysfunction and long-term graft failure: UNOS/OPTN database analysis. Kidney Int 65(5):1906–1913
  Article PubMed Google Scholar
• Lobo R, Cortez MS, Stevenson WC, Pruett TL (1995) Normocalcemic hyperparathyroidism associated with relatively low 1:25 vitamin D levels post-renal transplant can be successfully treated with oral calcitriol. Clin Transplant 9(4):277–281
  Google Scholar
• Rubello D et al (2005) Secondary hyperparathyroidism is associated with vitamin D receptor polymorphism and bone density after renal transplantation. Biomed Pharmacother 59(7):402–407
  Article PubMed CAS Google Scholar
• Messa P et al (1998) Persistent secondary hyperparathyroidism after renal transplantation. Kidney Int 54(5):1704–1713
  Article PubMed CAS Google Scholar
• Mikuls T et al (2003) Bone mineral density changes within six months of renal transplantation. Transplantation 75(1):49–54
  Article PubMed CAS Google Scholar
• de Sevaux R et al (2003) Abnormal vitamin D metabolism and loss of bone mass after renal transplantation. Nephron Physiol 93(1):C21–C28
  Article Google Scholar
• Kim H et al (1998) Bone mineral density after renal transplantation. Transplant Proc 30(7):3029–3030
  Article PubMed CAS Google Scholar
• Abdallah K et al (2006) Improvement of adynamic bone disease after renal transplantation. Braz J Med Biol Res 39(1):31–41
  Article PubMed CAS Google Scholar
• Julian et al (1991) Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 325(8):544–550
  Article PubMed CAS Google Scholar
• Levey A et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130(6):461–470
  PubMed CAS Google Scholar
• Brandenburg V, Westenfeld R, Ketteler M (2004) The fate of bone after renal transplantation. J Nephrol 17(2):190–204
  PubMed Google Scholar
• Silver J, Levi R (2005) Regulation of PTH synthesis and secretion relevant to the management of secondary hyperparathyroidism in chronic kidney disease. Kidney Int Suppl 95:S8–S12
  Article PubMed CAS Google Scholar
• Levi R, Silver J (2005) Pathogenesis of parathyroid dysfunction in end-stage kidney disease. Pediatr Nephrol 20(3):342–345
  Article PubMed Google Scholar
• Gutierrez O et al (2005) Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 16(7):2205–2215
  Article PubMed CAS Google Scholar
• Reichel H et al (2003) Influence of PTH assay methodology on differential diagnosis of renal bone disease. Nephrol Dial Transplant 18(4):759–768
  Article PubMed CAS Google Scholar
• Bonnin M et al (1990) 1,25-Dihydroxycholecalciferol as measured by a radioreceptor assay in normal subjects and patients after kidney transplantation. Clin Chem 36(2):389–390
  PubMed CAS Google Scholar
• Bonnin M et al (1992) Serum calcitriol concentrations in the early follow-up after renal transplantation. Transplant Proc 24(1):103–104
  PubMed CAS Google Scholar
• Querings K et al (2006) 25-hydroxyvitamin D deficiency in renal transplant recipients. J Clin Endocrinol Metab 91(2):526–529
  Article PubMed CAS Google Scholar
• Reinhardt W et al (1998) Sequential changes of biochemical bone parameters after kidney transplantation. Nephrol Dial Transplant 13(2):436–442
  Article PubMed CAS Google Scholar
• Riancho J et al (1988) Serum levels of 1,25-dihydroxyvitamin D after renal transplantation. Miner Electrolyte Metab 14(6):332–337
  PubMed CAS Google Scholar
• Stein B et al (1991) Cyclosporin-A increases synthesis of 1,25-dihydroxyvitamin D3 in the rat and mouse. Endocrinology 128(3):1369–1373
  PubMed CAS Google Scholar
• Henry H (1981) 25(OH)D3 metabolism in kidney cell cultures: lack of a direct effect of estradiol. Am J Physiol 240(2):E119–E124
  PubMed CAS Google Scholar
• Gallagher J, B Riggs, DeLuca H (1980) Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis. J Clin Endocrinol Metab 51(6):1359–1364
  Article PubMed CAS Google Scholar
• Heaf J et al (2003) Hyperparathyroidism and long-term bone loss after renal transplantation. Clin Transplant 17(3):268–274
  Article PubMed Google Scholar
• Palmer S, McGregor D, Strippoli G (2005) Interventions for preventing bone disease in kidney transplant recipients. Cochrane Database Syst Rev 2:CD005015
  PubMed Google Scholar
• Stempfle H et al (1999) Prevention of osteoporosis after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol. Transplantation (Baltimore) 68(4):523–530
  CAS Google Scholar
• Torres A et al (2004) Treatment with intermittent calcitriol and calcium reduces bone loss after renal transplantation. Kidney Int 65(2):705–712
  Article PubMed CAS Google Scholar
• Wissing K et al (2005) A controlled study of vitamin D3 to prevent bone loss in renal-transplant patients receiving low doses of steroids. Transplantation (Baltimore) 79(1):108–115
  CAS Google Scholar
• Al-Gabri S et al (2005) Changes in bone mineral density and selected metabolic parameters over 24 months following renal transplantation. Transplant Proc 37(2):1014–1019
  Article PubMed CAS Google Scholar
• Carling T et al (1997) Vitamin D receptor polymorphisms correlate to parathyroid cell function in primary hyperparathyroidism. J Clin Endocrinol Metab 82(6):1772–1775
  Article PubMed CAS Google Scholar
• Giannini S et al (2002) The effects of vitamin D receptor polymorphism on secondary hyperparathyroidism and bone density after renal transplantation. J Bone Miner Res 17(10):1768–1773
  Article PubMed CAS Google Scholar
• Toro J, Gentil MA, Garcia R, Perez-Valdivia MA et al (2005) Alendronate in kidney transplant patients: a single-center experience. Transplant Proc 37(3):1471–1472
  Google Scholar
• Falkiewicz K, BidziDska B, Demissie M, BoratyDska M, Zmonarski SC, Tworowska K et al (2005) Influence of vitamin D receptor gene polymorphisms on secondary hyperparathyroidism and bone density after kidney transplantation. Transplant Proc 37(2):1023–1025
  Google Scholar
• Bover J, Bosch R (1999) Vitamin D receptor polymorphisms as a determinant of bone mass and PTH secretion: from facts to controversies. Nephrol Dial Transplant 14(5):1066–1068
  Article PubMed CAS Google Scholar
• Hullett D, Laeseke PF, Malin G, Nessel R et al (2005) Prevention of chronic allograft nephropathy with vitamin D. Transpl Int 18(10):1175–1186
  Google Scholar
• Sezer S, Uyar M, Arat Z, Ozdemir FN et al (2005) Potential effects of 1,25-dihydroxyvitamin D3 in renal transplant recipients. Transplant Proc 37(7):3109–3111
  Google Scholar